B-NHL

Clinical trials for B-NHL explained in plain language.

Never miss a new study

Get alerted when new B-NHL trials appear

Sign up with your email to follow new studies for B-NHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Engineered immune cells show promise against tough childhood cancers

Disease control Completed

This study tested a new treatment for children and young adults (ages 1–39) with leukemia or lymphoma that did not respond to standard therapy. The treatment involved taking a patient's own white blood cells, modifying them in a lab to target a protein called CD22 on cancer cells…

Matched conditions: B-NHL

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 28, 2026 13:02 UTC

B-NHL

Get alerted when new B-NHL trials appear

Engineered immune cells show promise against tough childhood cancers